Improving clinical trials awareness and recruitment is not a ‘healthcare’ issue – it’s an ‘everyone’ issue – and a new event taking place next week aims to generate ideas to i
Problems at a contract manufacturing organisation have scuppered Eli Lilly’s hopes of a timely FDA approval for lebrikizumab, its IL-13 inhibitor for the treatment of atop
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho
